BMRN
Biomarin Pharmaceutical Inc
57.20$
-2.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 18.1% | 21.4% | 16.5% | 17.7% | 17.8% | 21.2% | 22.0% | 21.2% | 20.1% | 21.2% | 22.3% | 20.0% | 21.0% | 21.1% | 22.2% | 22.8% | 39.6% | 27.9% | 24.7% | 25.3% | 25.3% | 26.6% | 22.5% | 23.1% | 23.0% | 23.7% | 22.7% | 21.9% | 22.0% | 21.0% | 19.3% | 18.3% | 25.3% | 18.2% | 20.3% | 18.2% | 18.0% | 33.7% | 25.4% | 20.5% | 24.5% | |
| 81.9% | 78.6% | 83.5% | 82.3% | 82.2% | 78.8% | 78.0% | 78.8% | 79.9% | 78.8% | 77.7% | 80.0% | 79.0% | 78.9% | 77.8% | 77.2% | 60.4% | 72.1% | 75.3% | 74.7% | 74.7% | 73.4% | 77.5% | 76.9% | 77.0% | 76.3% | 77.3% | 78.1% | 78.0% | 79.0% | 80.7% | 81.7% | 74.7% | 81.8% | 79.7% | 81.8% | 82.0% | 66.3% | 74.6% | 79.5% | 75.5% | |
| 57.5% | 58.4% | 47.7% | 45.1% | 46.1% | 47.1% | 49.3% | 47.1% | 41.2% | 49.7% | 45.8% | 47.9% | 37.5% | 38.0% | 28.3% | 42.4% | 30.8% | 34.7% | 30.6% | 32.1% | 38.6% | 35.8% | 31.0% | 29.6% | 31.2% | 32.1% | 28.8% | 29.8% | 32.9% | 31.9% | 31.6% | 25.8% | 24.8% | 23.2% | 21.3% | 19.5% | 52.8% | 22.0% | 23.3% | 20.9% | 29.0% | |
| 42.4% | 47.6% | 39.5% | 45.2% | 19.0% | 44.7% | 37.0% | 41.1% | 37.9% | 46.5% | 40.5% | 18.8% | 36.9% | 41.3% | 18.4% | 18.3% | 16.4% | 43.2% | 16.5% | 16.6% | 21.1% | 23.2% | 17.3% | 16.4% | 20.9% | 22.5% | 17.7% | 15.2% | 8.7% | 21.9% | 16.4% | 19.7% | 19.4% | 18.9% | 13.9% | 13.4% | 17.7% | 91.7% | 17.4% | 25.6% | 38.9% | |
| 103.3% | 108.5% | 90.2% | 94.5% | 86.3% | 62.6% | 89.8% | 85.6% | 83.9% | 89.6% | 91.2% | 90.7% | 78.1% | 80.9% | 56.9% | 86.7% | 72.1% | 82.0% | 70.1% | 72.3% | 87.7% | 88.0% | 51.0% | 69.6% | 77.5% | 80.9% | 66.8% | 67.0% | 72.7% | 76.8% | 67.1% | 64.8% | 59.5% | 60.2% | 49.6% | 48.3% | 88.0% | 57.2% | 57.6% | 68.3% | 67.5% | |
| -21.5% | -29.9% | -6.7% | -12.2% | -4.1% | 16.2% | -11.9% | -6.8% | -4.0% | -10.8% | -13.5% | -10.7% | 0.9% | -2.0% | 20.9% | -9.5% | -11.7% | -9.9% | 5.2% | 2.3% | -13.0% | -14.6% | 26.4% | 7.3% | -0.5% | -4.6% | 10.5% | 11.0% | 5.3% | 2.2% | 13.6% | 16.9% | 15.3% | 21.6% | 30.0% | 33.5% | -6.0% | 9.1% | 16.9% | 11.2% | 8.0% | |
| 3.6% | 3.2% | 3.3% | 3.2% | 3.3% | 3.3% | 3.1% | 3.3% | 3.1% | 2.2% | 1.7% | 1.8% | 0.6% | 1.5% | 1.4% | 1.9% | 2.0% | 1.1% | 0.8% | 0.8% | 0.9% | 0.9% | 0.7% | 0.7% | 0.9% | 0.7% | 0.6% | 0.6% | 0.7% | 0.9% | 0.5% | 0.5% | 0.4% | 0.3% | 0.4% | 0.3% | 0.3% | 0.3% | 2.0% | 6.4% | 2.5% | |
| -23.9% | -30.7% | -8.0% | -14.3% | -6.2% | 15.2% | -13.6% | -7.8% | -5.0% | -12.3% | -13.2% | -10.8% | 2.1% | -2.2% | 20.2% | -9.8% | -12.8% | -8.9% | 4.8% | 2.8% | -11.3% | -14.8% | 25.8% | 6.5% | -0.4% | -3.3% | 9.5% | 11.9% | 7.2% | 3.0% | 16.3% | 18.6% | 18.0% | 22.7% | 32.0% | 36.1% | -3.4% | -3.1% | 18.4% | 6.2% | 4.4% | |
| -10.5% | -4.5% | -2.6% | -2.7% | -2.4% | 29.6% | -1.8% | -3.3% | -1.7% | -11.2% | 0.9% | -1.2% | -9.8% | -5.5% | 4.0% | -3.0% | -177.4% | -13.8% | 1.2% | 0.2% | -2.4% | -1.9% | 2.6% | 1.3% | 0.9% | -3.2% | 1.0% | 2.5% | 0.2% | -0.2% | 2.6% | 3.5% | 3.8% | 6.0% | 7.0% | 6.9% | 0.6% | 2.2% | 4.7% | 1.7% | 2.2% | |
| -13.4% | -26.2% | -5.4% | -11.6% | -3.7% | -14.3% | -11.8% | -4.5% | -3.2% | -1.0% | -14.1% | -9.7% | 11.9% | 3.3% | 16.2% | -6.8% | 164.6% | 4.9% | 3.6% | 2.6% | -8.9% | -12.9% | 23.3% | 5.2% | -1.3% | 0.0% | 8.5% | 9.4% | 6.9% | 3.2% | 13.7% | 15.1% | 14.2% | 16.7% | 24.9% | 29.1% | -4.0% | -5.3% | 13.8% | 4.5% | 2.1% | |
| -10.1% | -21.1% | 1.4% | -5.5% | 2.9% | 26.3% | -4.4% | 0.8% | 4.6% | -3.2% | -5.9% | -2.4% | 9.4% | 4.9% | 26.7% | -2.2% | -5.2% | -1.8% | 11.3% | 9.0% | -3.8% | -8.3% | 31.8% | 12.0% | 5.5% | 1.9% | 14.6% | 16.8% | 12.2% | 8.0% | 21.0% | 22.8% | 21.0% | 26.2% | 35.3% | 38.7% | -0.7% | -0.5% | 22.5% | 22.5% | 11.3% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.